#BIO2015: Improving basic science research with a translational model
A new Battelle report examines new trends in translational science among academia-industry collaboration, and the impact it has on basic science research.
Ohio State and Battelle help paralyzed people move again by just thinking about it
From wheelchairs built like tanks to motorized exoskeletons, people who are paralyzed are gaining more and more ways to start moving on their own again. To add to this growth, The Ohio State University Wexner Medical Center and Battelle have partnered to create a device that lets people who are paralyzed move in a different way than ever […]
Battelle: All the biotech jobs are in CROs with 28% growth since 2001
The layoffs seen en masse in big pharma have been offset, in part, by a sharp rise in contract research employment – meaning job growth in the highly paid biosciences sector has remained generally steady among the nation’s many biotech clusters, according to a Battelle report released at the BIO International Conference. The nonprofit’s report […]
Trio awarded DARPA contract to create a portable device that treats sepsis
DARPA awarded Battelle, NxStage Medical and Aethlon Medical a contract to develop a device to treat sepsis, which can arise from as much as 10 percent of combat wounds, for military use, according to a Battelle press release. The contract, which could lead to $22.8 million dollars and four years worth of work for the […]
Battelle: Human Genome Project’s economic impact has reached nearly $1T in US (infographic)
In an attempt to calculate the ROI for an estimated $14.5 billion the U.S. government pumped into Human Genome Project-related research, Battelle has come up with an astonishing number: $1 trillion. Over the course of the last 24 years, projects related to sequencing the human genome have yielded an economic impact of $965 billion, including […]
Has Battelle got a technology licensing deal for you!
Need a Deep Web Miner to retrieve hard-to-find life sciences research? How about a cell therapy manufacturing system? A self-coiling surgical tool? Then Battelle might have the intellectual property for you.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Battelle, universities win $72.5M to end childhood obesity
The National Institutes of Health is launching two major research efforts -- worth $72.5 million -- to find ways to end the childhood obesity epidemic in the United States. Battelle's Health and Life Sciences Global Business has won a $23 million contract to study community programs for their roles in increasing or decreasing the risk of childhood obesity. Five universities will use $49.5 million to test long-term interventions through several levels of influence.
BIO 2010: Minnesota’s biotech sector languishes far behind medical devices
More evidence that Minnesota has a lot of work to do in developing a viable biotech industry. From 2004 to 2009, local human biotech firms attracted only $1 million in venture capital compared to $1.2 billion for medical devices, according to a report by Battelle Memorial Institute and the Biotechnology Industry Organization. $1 million over […]
Night Read (Ohio): US Endoscopy releases colonoscopy product
US Endoscopy, the endoscopy device design and manufacturing company in Mentor, has released the Entrada colonic overtube, which offers more control during colonoscopy in patients with tortuous sigmoid looping.
Battelle, OSU’s Technology Entrepreneurship and Commercialization Center strike deal
The Technology Entrepreneurship and Commercialization Center at Ohio State University's Fisher College of Business was created to assess the commercial and economic viability of technology developed at Battelle. The center, and the science and technology institute have struck a 2-year deal to work together.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Night Read (Ohio): Brookings Institution report calls for VC fund for Great Lakes states
Ohio and its neighboring states need a massive venture capital fund that pumps money into businesses, says a white paper, Turning up the Heat: How Venture Capital Can Help Fuel the Economic Transformation of the Great Lakes Region, released today by the Brookings Institution.
Artificial pancreas could be on the four-year horizon — MedCity Evening Read, Jan. 14, 2010
Ohio researchers take note: An experimental artificial pancreas soon will be tested in diabetes patients and could be commercially available in four years.
Neuros Medical chooses Battelle to co-develop neurostimulation device for chronic pain
Neuros Medical Inc. has chosen Battelle to help develop its neurostimulation device to block chronic pain. Neuros Medical is developing a "nerve block" system that stimulates nerves to block pain.
Invacare Corp. declassifies its board of directors to enhance corporate governance — MedCity Evening Read, Nov. 24, 2009
Elyria home health care company Invacare Corp. said Tuesday it has enhanced its corporate governance framework and policies, including agreeing to declassify its board of directors.
Weekend Rounds: Cleveland company aims stem cell therapies at targets
In the last week at MedCity News: Cell Targeting in Cleveland points stem cell therapies to specific areas of the body, Cleveland insurance broker and risk manager Oswald Cos. assembles panel that says health care reforms are too close to call, and Ohio State University and Battelle try to energize joint research and economic development efforts.